McHale Duncan 4
4 · Evelo Biosciences, Inc. · Filed Jan 29, 2021
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-27+96,500→ 96,500 totalExercise: $16.65Exp: 2031-01-27→ Common Stock (96,500 underlying)
Footnotes (1)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates.